We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+7.69%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$42.3B
AUM Growth
+$5.51B
Cap. Flow
+$3.13B
Cap. Flow %
7.41%
Top 10 Hldgs %
26.06%
Holding
1,338
New
111
Increased
793
Reduced
350
Closed
65

Top Buys

Rank Stock Value
1
SLB icon
SLB Ltd
SLB
+$238M
2
CGAU
Centerra Gold
CGAU
+$212M
3
HAL icon
Halliburton
HAL
+$181M
4
BKR icon
Baker Hughes
BKR
+$115M
5
NOW icon
ServiceNow
NOW
+$103M

Sector Composition

Rank Sector Weight
1 Materials 40.42%
2 Technology 21.38%
3 Energy 8.67%
4 Healthcare 6.57%
5 Financials 3.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLCA
176
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
$43.3M 0.1%
3,745,741
+2,047,684
+121% +$23.7M
LPX icon
177
Louisiana-Pacific
LPX
$5.23B
$43.2M 0.1%
716,463
-4,791
-0.7% -$306K
NLY icon
178
Annaly Capital Management
NLY
$17.5B
$43.1M 0.1%
1,214,663
-25,216
-2% -$916K
DAR icon
179
Darling Ingredients
DAR
$9.4B
$43.1M 0.1%
638,925
+3,801
+0.6% +$268K
NEE icon
180
NextEra Energy
NEE
$185B
$41.9M 0.1%
571,458
+343,870
+151% +$25.8M
TSCO icon
181
Tractor Supply
TSCO
$16.4B
$41.5M 0.1%
1,115,610
-127,645
-10% -$4.68M
GOOG icon
182
Alphabet (Google) Class C
GOOG
$4.17T
$39.7M 0.09%
316,780
-35,620
-10% -$4.25M
GTLS
183
DELISTED
Chart Industries
GTLS
$39.5M 0.09%
269,914
-1,240
-0.5% -$182K
V icon
184
Visa
V
$705B
$39.5M 0.09%
168,863
+2,705
+2% +$618K
RES icon
185
RPC Inc
RES
$1.14B
$39.5M 0.09%
7,971,307
+4,436,206
+125% +$23.9M
OBDC icon
186
Blue Owl Capital
OBDC
$5.42B
$38.2M 0.09%
2,679,651
+1,291,015
+93% +$18.6M
UNP icon
187
Union Pacific
UNP
$173B
$37M 0.09%
168,428
+7,202
+4% +$1.6M
TSLA icon
188
Tesla
TSLA
$1.21T
$36.9M 0.09%
163,035
-11,586
-7% -$2.52M
HD icon
189
Home Depot
HD
$341B
$36.8M 0.09%
115,403
+19,712
+21% +$6.27M
MRNA icon
190
Moderna
MRNA
$22B
$36.7M 0.09%
156,032
-68,988
-31% -$12.3M
REGN icon
191
Regeneron Pharmaceuticals
REGN
$73.1B
$36.6M 0.09%
65,600
+3,649
+6% +$1.85M
UNH icon
192
UnitedHealth
UNH
$387B
$36.6M 0.09%
91,304
+12,294
+16% +$4.9M
ILMN icon
193
Illumina
ILMN
$29.5B
$35.8M 0.08%
77,810
+6,101
+9% +$2.46M
ORLA
194
Orla Mining
ORLA
$3.4B
$35.5M 0.08%
8,599,944
+659,568
+8% +$2.73M
TROX icon
195
Tronox
TROX
$991M
$35M 0.08%
1,561,342
+98,236
+7% +$2.16M
CNH
196
CNH Industrial
CNH
$13.6B
$34.3M 0.08%
2,357,356
+67,732
+3% +$967K
STEM icon
197
Stem
STEM
$46.4M
$34.3M 0.08%
47,604
-11,211
-19% -$6.1M
MUX icon
198
McEwen Inc
MUX
$1.02B
$33.5M 0.08%
2,425,844
+191,756
+9% +$2.54M
GATO
199
DELISTED
Gatos Silver, Inc.
GATO
$33.3M 0.08%
1,906,753
+23,557
+1% +$332K
ALXN
200
DELISTED
Alexion Pharmaceuticals
ALXN
$33M 0.08%
179,488
+4,396
+3% +$755K

Similar funds

VanEck Associates's Q2 2021 Portfolio in Review

As of Q2 2021, VanEck Associates held 1,338 positions worth $42.3B, up 15% from $36.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

VanEck Associates deployed $3.13B of net new capital in Q2 2021, opening 111 new positions and adding to 793 existing holdings. Its largest new stake was Centerra Gold: 25,491,475 shares worth $193M.

By sector, the portfolio is most concentrated in Materials at 40% of assets, down from 43% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Gold Fields, an estimated $374M trimmed.

  • VanEck Associates's largest Q2 2021 buy was Centerra Gold: 25,491,475 shares worth $193M.
  • VanEck Associates added most to SLB Ltd in Q2 2021, an estimated $238M increase.
  • VanEck Associates's biggest Q2 2021 reduction was Gold Fields, cutting an estimated $374M.
  • VanEck Associates fully exited John Wiley & Sons Class A in Q2 2021, selling an estimated $96.5M.
  • VanEck Associates's ten largest holdings make up 26% of its $42.3B portfolio in Q2 2021.
  • VanEck Associates opened 111 new positions and closed 65 in Q2 2021.
  • VanEck Associates's portfolio value rose 15% quarter-over-quarter to $42.3B.

Based on VanEck Associates's 13F filing for Q2 2021, filed 10 Aug 2021.